Proteotoxicity in Inflammation & Dementia

This feed focuses on proteotoxicity, which plays an important role in aging-associated inflammation of the CNS and is a major hallmark of different neurodegenerative disorders. Discover the latest research on proteotoxicity in inflammation and neurodegeneration here.

October 13, 2021
Open Access

C9ORF72 Repeat Expansion Affects the Proteome of Primary Skin Fibroblasts in ALS.

International Journal of Molecular Sciences
Marta LualdiMauro Fasano
October 11, 2021

Loss-of-function mutation in VCP mimics the characteristic pathology as in FTLD-TARDBP.

Abubakar Wani, Conrad C Weihl
October 7, 2021
Open Access

Cholinergic Receptor Modulation as a Target for Preventing Dementia in Parkinson's Disease.

Frontiers in Neuroscience
Alexandre IarkovValentina Echeverria
October 5, 2021

Mechanistic Insight into the Design of Chemical Tools to Control Multiple Pathogenic Features in Alzheimer's Disease.

Accounts of Chemical Research
Jiyeon HanMi Hee Lim
October 4, 2021

Asaronic acid inhibits ER stress sensors and boosts functionality of ubiquitin-proteasomal degradation in 7β-hydroxycholesterol-loaded macrophages.

Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
Hyeongjoo OhYoung-Hee Kang
October 2, 2021

Solar simulated ultraviolet radiation inactivates HCoV-NL63 and SARS-CoV-2 coronaviruses at environmentally relevant doses.

Journal of Photochemistry and Photobiology. B, Biology
Georg T WondrakDominik Schenten
October 1, 2021
Open Access

Loss of presenilin function enhances tau phosphorylation and aggregation in mice.

Acta Neuropathologica Communications
Carlos M Soto-FaguásCarlos A Saura
October 1, 2021

Defining circadian disruption in neurodegenerative disorders.

The Journal of Clinical Investigation
Christopher S Colwell
September 29, 2021
Open Access

Alzheimer's Disease: A Molecular View of β-Amyloid Induced Morbific Events.

Rajmohamed Mohamed AsikParasuraman Padmanabhan
September 29, 2021

Pharmacotherapeutic Potential of Garlic in Age-Related Neurological Disorders.

CNS & Neurological Disorders Drug Targets
Ramin Ahangar-SirousNiloofar Deravi
September 27, 2021
Open Access

Nerve Growth Factor-Based Therapy in Alzheimer's Disease and Age-Related Macular Degeneration.

Frontiers in Neuroscience
Giuseppina AmadoroAlessandra Micera
September 23, 2021
Open Access

Revisit the Cellular Transmission and Emerging Techniques in Proteinopathies
JIngwen JiangQihui Wu
September 23, 2021

Autophagy in Alzheimer's disease pathogenesis: Therapeutic potential and future perspectives.

Ageing Research Reviews
Zhigang ZhangJie Tu
September 17, 2021

A critical appraisal of tau-targeting therapies for primary and secondary tauopathies.

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Bruno P ImbimboClaudia Balducci
September 16, 2021

Neuroinflammatory Signaling in the Pathogenesis of Alzheimer's Disease.

Current Neuropharmacology
Md Sahab UddinGhulam Md Ashraf
September 16, 2021

Control of hippocampal pKr-2 expression reduces neurotoxic symptoms in 5XFAD mice.

British Journal of Pharmacology
Sehwan KimSang Ryong Kim
September 14, 2021

Altered ceramide metabolism is a feature in the extracellular vesicle-mediated spread of alpha-synuclein in Lewy body disorders.

Acta Neuropathologica
Marzena Kurzawa-AkanbiChristopher M Morris
September 10, 2021
Open Access

Collusion of α-Synuclein and Aβ aggravating co-morbidities in a novel prion-type mouse model.

Molecular Neurodegeneration
Grace M LloydDavid R Borchelt
September 10, 2021
Open Access

Acetylcholinesterase Inhibitors in the Treatment of Neurodegenerative Diseases and the Role of Acetylcholinesterase in their Pathogenesis.

International Journal of Molecular Sciences
Łucja Justyna Walczak-Nowicka, Mariola Herbet

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved